Adherence thresholds for emtricitabine-tenofovir disoproxil fumarate preexposure prophylaxis against HIV acquisition in cisgender women: A randomized directly observed dosing study
Authors
Elex Hill (ORCID: https://orcid.org/0000-0002-1338-2592)
Sarah Mbaire
David V. Glidden (ORCID: https://orcid.org/0000-0001-5888-1419)
Susan Morrison (ORCID: https://orcid.org/0009-0000-8826-8076)
Adherence thresholds for emtricitabine-tenofovir disoproxil fumarate preexposure prophylaxis against HIV acquisition in cisgender women: A randomized directly observed dosing study
Elex Hill, Sarah Mbaire, David V. Glidden, Susan Morrison et al.
Citations
2 citations
Journal
PLoS Medicine
Topics
HIV/AIDS Research and Interventions
Field-Weighted Citation Impact (FWCI)
2.79
article
Adherence thresholds for emtricitabine-tenofovir disoproxil fumarate preexposure prophylaxis against HIV acquisition in cisgender women: A randomized directly observed dosing study
Elex Hill, Sarah Mbaire, David V. Glidden, Susan Morrison, Nelly Mugo, Kenneth Ngure, Linxuan Wu, Kenneth K. Mugwanya, Corwin Coppinger, Irene Njeru, Peter L. Anderson, Bhavna Chohan, Jared M. Baeten, Deborah Donnell, Marianne Mureithi, Mary Morrow, Torin Schaafsma, Samantha MaWhinney, Lane R. Bushman, Clare Brown, Mary Kibatha, Nina Akelo, M. Saina, Elena A. Rechkina, Eric Koome
article en
2 citations
Abstract
No abstract available for this paper.
Publication Tag
PLoS MedicineVol. 22(9)
Institutions
University of California, San Francisco (US), University of Washington (US), Jomo Kenyatta University of Agriculture and Technology (KE), Kenya Medical Research Institute (KE), Fred Hutch Cancer Center (US), University of Colorado Anschutz Medical Campus (US)